Following the success of 3 randomized trials and 1 open-label extension trial, the US Food and Drug Administration has approved a new sublingual tablet for the treatment of certain adults with nocturia.
...
In an effort to improve access to prevention and treatment for opioid dependence, the FDA has prioritized the approval of generic versions of medication-assisted treatment options.
The US Food and Drug Administration has approved a new once-daily oral tablet for the treatment of osteoarthritis pain. The drug also contains a built-in antihypertensive.
The US Food and Drug Administration has approved the expansion of the indication of tofacitinib to include some adults with ulcerative colitis, making it the first oral medication approved for chronic use...
The US Food and Drug Administration has approved a new product for the treatment of moderate-to-severe dyspareunia, a symptom of vulvar and vaginal atrophy due to menopause.
The US Food and Drug Administration has approved a subcutaneous injection for the treatment of a rare and serious genetic disease involving the inability to break down phenylananine.
